Found: 22
Select item for more details and to access through your institution.
Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0200823
- By:
- Publication type:
- Article
Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity‐score matched analysis.
- Published in:
- Journal of Surgical Oncology, 2020, v. 121, n. 5, p. 823, doi. 10.1002/jso.25823
- By:
- Publication type:
- Article
Clinico‐pathological features and survival of patients with malignant exocrine pancreatic neoplasms: The AC Camargo Cancer Center experience.
- Published in:
- Journal of Surgical Oncology, 2019, v. 119, n. 1, p. 71, doi. 10.1002/jso.25312
- By:
- Publication type:
- Article
Role of staging laparoscopy in the management of Pancreatic Duct Carcinoma (PDAC): Single‐center experience from a tertiary hospital in Brazil.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 5, p. 819, doi. 10.1002/jso.25024
- By:
- Publication type:
- Article
Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre.
- Published in:
- Ecancermedicalscience, 2022, v. 16, n. 1338-1346, p. 1, doi. 10.3332/ecancer.2022.1345
- By:
- Publication type:
- Article
Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis.
- Published in:
- Ecancermedicalscience, 2021, v. 15, n. 1264-1315, p. 1, doi. 10.3332/ecancer.2021.1276
- By:
- Publication type:
- Article
Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian network meta-analysis.
- Published in:
- Ecancermedicalscience, 2021, v. 15, n. 1264-1315, p. 1, doi. 10.3332/ecancer.2021.1276
- By:
- Publication type:
- Article
Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysis.
- Published in:
- Ecancermedicalscience, 2020, v. 14, n. 996-1019, p. 1, doi. 10.3332/ecancer.2020.1014
- By:
- Publication type:
- Article
The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. e854, doi. 10.1634/theoncologist.2018-0741
- By:
- Publication type:
- Article
Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919874650
- By:
- Publication type:
- Article
Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, Brazil.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85759-5
- By:
- Publication type:
- Article
Epidemiological Profile and Treatment Outcomes in Young Adults (19-29 Years of Age) Treated for Cancer in a Tertiary Hospital in São Paulo, Brazil.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2017, v. 6, n. 2, p. 333, doi. 10.1089/jayao.2016.0047
- By:
- Publication type:
- Article
The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 679, doi. 10.3390/cancers16030679
- By:
- Publication type:
- Article
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5015, doi. 10.3390/cancers15205015
- By:
- Publication type:
- Article
Current Molecular Profile of Gastrointestinal Stromal Tumors and Systemic Therapeutic Implications.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5330, doi. 10.3390/cancers14215330
- By:
- Publication type:
- Article
Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist's Perspective.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2023, p. 1, doi. 10.1177/10732748231173212
- By:
- Publication type:
- Article
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2023, p. 1, doi. 10.1177/10732748221149543
- By:
- Publication type:
- Article
Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 7, p. 631, doi. 10.1159/000508632
- By:
- Publication type:
- Article
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241265213
- By:
- Publication type:
- Article